Levels of pentraxin-3 in gingival crevicular fluid and plasma in periodontal health and disease

Journal of Periodontology

Volumn 82, Issue 5, 2011, Pages 734-741

  Pradeep, A R ^a   Kathariya, Rahul ^a   Raghavendra, N M ^a   Sharma, Anuj ^a  

^a GOVERNMENT DENTAL COLLEGE AND RESEARCH INSTITUTE   (India)

Author keywords

Acute phase proteins; C reactive protein; Chronic periodontitis; Gingival crevicular fluid; Pentraxin 3; Plasma

Indexed keywords

ACUTE PHASE PROTEIN; C REACTIVE PROTEIN; PENTRAXIN 3; SERUM AMYLOID P;

ADULT; ALVEOLAR BONE LOSS; ARTICLE; BLOOD; CASE CONTROL STUDY; CHEMISTRY; CHRONIC PERIODONTITIS; CLASSIFICATION; COMPARATIVE STUDY; DISEASE COURSE; FEMALE; GINGIVITIS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PERIODONTAL DISEASE; PERIODONTAL POCKET; PERIODONTICS; PERIODONTIUM;

ACUTE-PHASE PROTEINS; ADULT; ALVEOLAR BONE LOSS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHRONIC PERIODONTITIS; DISEASE PROGRESSION; FEMALE; GINGIVAL CREVICULAR FLUID; GINGIVITIS; HUMANS; MALE; MIDDLE AGED; PERIODONTAL ATTACHMENT LOSS; PERIODONTAL DISEASES; PERIODONTAL INDEX; PERIODONTAL POCKET; PERIODONTIUM; SERUM AMYLOID P-COMPONENT; YOUNG ADULT;

EID: 79955632229     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2010.100526     Document Type: Article

References (50)

1. Giannobile WV. Host-response therapeutics for periodontal diseases. J Periodontol 2008;79(Suppl. 8):1592-1600.
2. Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, Van der Velden U. Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 2000;71:1528-1534.
3. Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS. Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res 2000;79:49-57. (Pubitemid 32501322)
4. De Nardin E. The role of inflammatory and immunological mediators in periodontitis and cardiovascular disease. Ann Periodontol 2001;6:30-40.
5. Caffesse RG, Nasjleti CE. Enzymatic penetration through intact sulcular epithelium. J Periodontol 1976;47:391-397.
6. Saglie R, Newman MG, Carranza FA Jr., Pattison GL. Bacterial invasion of gingiva in advanced periodontitis in humans. J Periodontol 1982;53:217-222. (Pubitemid 12039267)
7. Schwartz J, Stinson FL, Parker RB. The passage of tritiated bacterial endotoxin across intact gingival crevicular epithelium. J Periodontol 1972;43:270-276.
8. Tüter G, Kurtis B, Serdar M. Evaluation of gingival crevicular fluid and serum levels of high-sensitivity C-reactive protein in chronic periodontitis patients with or without coronary artery disease. J Periodontol 2007;78:2319-2324.
9. Fitzsimmons TR, Sanders AE, Bartold PM, Slade GD. Local and systemic biomarkers in gingival crevicular fluid increase odds of periodontitis. J Clin Periodontol 2010;37:30-36.
10. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001;72:1221-1227. (Pubitemid 33607184)
11. Ebersole JL. Systemic humoral immune responses in periodontal disease. Crit Rev Oral Biol Med 1990;1:283-331. (Pubitemid 20361899)
12. Trautwein C, Böker K, Manns MP. Hepatocyte and immune system: Acute phase reaction as a contribution to early defence mechanisms. Gut 1994;35:1163-1166. (Pubitemid 24277324)
13. Hollister MC, Weintraub JA. The association of oral status with systemic health, quality of life, and economic productivity. J Dent Educ 1993;57:901-912.
14. Mantovani A, Garlanda C, Doni A, Bottazzi B. Pentraxins in innate immunity: From C-reactive protein to the long pentraxin PTX3. J Clin Immunol 2008;28:1-13.
15. Garlanda C, Bottazzi B, Bastone A, Mantovani A. Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility. Annu Rev Immunol 2005;23:337-366. (Pubitemid 40563173)
16. Bottazzi B, Vouret-Craviari V, Bastone A, et al. Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem 1997;272:32817-32823. (Pubitemid 28023616)
17. Mantovani A, Garlanda C, Bottazzi B. Pentraxin 3, a non-redundant soluble pattern recognition receptor involved in innate immunity. Vaccine 2003;21(Suppl. 2):S43-S47. (Pubitemid 36588649)
18. Lee GW, Lee TH, Vilcek J. TSG-14, a tumor necrosis factor-and IL-1-inducible protein, is a novel member of the pentaxin family of acute phase proteins. J Immunol 1993;150:1804-1812. (Pubitemid 23129656)
19. Goodman AR, Cardozo T, Abagyan R, Altmeyer A, Wisniewski HG, Vilcek J. Long pentraxins: An emerging group of proteins with diverse functions. Cytokine Growth Factor Rev 1996;7:191-202. (Pubitemid 27198077)
20. Jaillon S, Peri G, Delneste Y, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med 2007;204:793-804. (Pubitemid 46631609)
21. Goodman AR, Levy DE, Reis LF, Vilcek J. Differential regulation of TSG-14 expression in murine fibroblasts and peritoneal macrophages. J Leukoc Biol 2000;67:387-395.
22. Alles VV, Bottazzi B, Peri G, Golay J, Introna M, Mantovani A. Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes. Blood 1994;84:3483-3493. (Pubitemid 24352913)
23. Doni A, Michela M, Bottazzi B, et al. Regulation of PTX3, a key component of humoral innate immunity in human dendritic cells: Stimulation by IL-10 and inhibition by IFN-gamma. J Leukoc Biol 2006;79:797-802. (Pubitemid 44835611)
24. Nauta AJ, de Haij S, Bottazzi B, et al. Human renal epithelial cells produce the long pentraxin PTX3. Kidney Int 2005;67:543-553. (Pubitemid 40139846)
25. Gustin C, Delaive E, Dieu M, Calay D, Raes M. Upregulation of pentraxin-3 in human endothelial cells after lysophosphatidic acid exposure. Arterioscler Thromb Vasc Biol 2008;28:491-497.
26. Klouche M, Peri G, Knabbe C, et al. Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells. Atherosclerosis 2004;175:221-228. (Pubitemid 38942901)
27. Nauta AJ, Bottazzi B, Mantovani A, et al. Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. Eur J Immunol 2003;33:465-473. (Pubitemid 36267612)
28. Okutani D. The role of long pentraxin 3, a new inflammatory mediator in inflammatory responses [in Japanese]. Nihon Rinsho Meneki Gakkai Kaishi 2006;29:107-113.
29. Fazzini F, Peri G, Doni A, et al. PTX3 in small-vessel vasculitides: An independent indicator of disease activity produced at sites of inflammation. Arthritis Rheum 2001;44:2841-2850. (Pubitemid 34016204)
30. Löe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21:533-551.
31. Saito T, Murakami M, Shimazaki Y, Oobayashi K, Matsumoto S, Koga T. Association between alveolar bone loss and elevated serum C-reactive protein in Japanese men. J Periodontol 2003;74:1741-1746. (Pubitemid 38181215)
32. Johnson NW, Griffiths GS, Wilton JM, et al. Detection of high-risk groups and individuals for periodontal diseases. Evidence for the existence of high-risk groups and individuals and approaches to their detection. J Clin Periodontol 1988;15:276-282.
33. Sharma CG, Pradeep AR. Gingival crevicular fluid osteopontin levels in periodontal health and disease. J Periodontol 2006;77:1674-1680. (Pubitemid 44680230)
34. Pradeep AR, Daisy H, Hadge P, Garg G, Thorat M. Correlation of gingival crevicular fluid interleukin-18 and monocyte chemoattractant protein-1 levels in periodontal health and disease. J Periodontol 2009;80:1454-1461.
35. Savchenko A, Imamura M, Ohashi R, et al. Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions. J Pathol 2008;215:48-55. (Pubitemid 351619875)
36. Inoue K, Sugiyama A, Reid PC, et al. Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris. Arterioscler Thromb Vasc Biol 2007;27:161-167. (Pubitemid 46360394)
37. Peri G, Introna M, Corradi D, et al. PTX3, A prototypical long pentraxin, is an early indicator of acute myocardial infarction in humans. Circulation 2000;102:636-641. (Pubitemid 30640663)
38. Reading PC, Bozza S, Gilbertson B, et al. Antiviral activity of the long chain pentraxin PTX3 against influenza viruses. J Immunol 2008;180:3391-3398.
39. Latini R, Maggioni AP, Peri G, et al. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2004;110:2349-2354. (Pubitemid 39407338)
40. Tong M, Carrero JJ, Qureshi AR, et al. Plasma pentraxin 3 in patients with chronic kidney disease: Associations with renal function, protein-energy wasting, cardiovascular disease, and mortality. Clin J Am Soc Nephrol 2007;2:889-897.
41. Luchetti MM, Piccinini G, Mantovani A, et al. Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA). Clin Exp Immunol 2000;119:196-202. (Pubitemid 30064610)
42. Cetin I, Cozzi V, Pasqualini F, et al. Elevated maternal levels of the long pentraxin 3 (PTX3) in preeclampsia and intrauterine growth restriction. Am J Obstet Gynecol 2006;194:1347-1353.
43. Kato S, Ochiai M, Sakurada T, et al. Increased expression of long pentraxin PTX3 in inflammatory bowel diseases. Dig Dis Sci 2008;53:1910-1916.
44. Mairuhu AT, Peri G, Setiati TE, et al. Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections. J Med Virol 2005;76:547-552. (Pubitemid 40943266)
45. Muller B, Peri G, Doni A, et al. Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Crit Care Med 2001;29:1404-1407. (Pubitemid 32641804)
46. Pradeep AR, Manjunath RS, Kathariya R. Progressive periodontal disease has a simultaneous incremental elevation of gingival crevicular fluid and serum CRP levels. J Invest Clin Dent 2010;1:133-138.
47. Hussain Bokhari SA, Khan AA, Tatakis DN, Azhar M, Hanif M, Izhar M. Non-surgical periodontal therapy lowers serum inflammatory markers: A pilot study. J Periodontol 2009;80:1574-1580.
48. Mattila K, Vesanen M, Valtonen V, et al. Effect of treating periodontitis on C-reactive protein levels: A pilot study. BMC Infect Dis 2002;2:30.
49. Marcaccini AM, Meschiari CA, Sorgi CA, et al. Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects. J Periodontol 2009;80:594-602.
50. Paraskevas S, Huizinga JD, Loos BG. A systematic review and meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 2008;35:277-290.